Cancer drug trial for tough lymphoma halted early – what we know
Disease control
Terminated
This study tested an experimental drug called ASTX660 in people with certain types of T-cell lymphoma that had returned or stopped responding to standard treatments. The trial was stopped early after enrolling only 8 participants. The main goals were to check the drug's safety an…
Phase: PHASE1, PHASE2 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 09:24 UTC